Skip to content

Elucidation of the effects of smoking cessation on gut microbiome, metabolites, and systemic inflammation

Elucidation of the effects of smoking cessation on gut microbiome, metabolites, and systemic inflammation - KSCR

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000054308
Enrollment
400
Registered
2024-05-02
Start date
2024-04-16
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

none

Interventions

None listed

Sponsors

Keio University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: A. Smoking cessation clinic patients: (1) Japanese nationals 20 years of age or older. (2) Those who have started their first visit to a smoking cessation clinic. (3) Have given written consent to participate in this study. B. Healthy volunteers: (1) Japanese who are 20 years of age or older (2) Non-smokers (3) Have given written consent to participate in this study.

Exclusion criteria

Exclusion criteria: A. Smoking cessation clinic patients: (1) Patients who have already quit smoking at the time of their first visit to a smoking cessation clinic (2) Patients with a history of intestinal tract surgery (3) Persons deemed inappropriate by the principal investigator or subinvestigator to conduct this study. B. Healthy volunteers: (1) Those who have a history of intestinal tract surgery (2) Persons with a history of smoking in the past (3) Persons who are deemed inappropriate by the principal investigator or subinvestigator to conduct this study.

Design outcomes

Primary

MeasureTime frame
Comprehensive analysis of the bacterial flora in stools will be performed before and after smoking cessation and compared.

Secondary

MeasureTime frame
Evaluation of blood and stool metabolites, systemic inflammation, and in vivo characteristics of the intestinal microflora in the stool, measurement of salivary cotinine to assess nicotine in the body, and assessment of living conditions using a questionnaire will be conducted before and after smoking cessation and compared.

Countries

Japan

Contacts

Public ContactShotaro Chubachi

Keio University School of Medicine Division of Pulmonary Medicine

bachibachi472000@keio.jp03-5363-3793

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026